Shockwave Medical Stock Performance
SWAV Stock | USD 328.54 0.06 0.02% |
On a scale of 0 to 100, Shockwave Medical holds a performance score of 21. The entity has a beta of 0.87, which indicates possible diversification benefits within a given portfolio. Shockwave Medical returns are very sensitive to returns on the market. As the market goes up or down, Shockwave Medical is expected to follow. Please check Shockwave Medical's potential upside, as well as the relationship between the accumulation distribution and period momentum indicator , to make a quick decision on whether Shockwave Medical's existing price patterns will revert.
Risk-Adjusted Performance
21 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Shockwave Medical are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Shockwave Medical showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.0974 | Five Day Return 0.43 | Year To Date Return 68.99 | Ten Year Return 978.43 | All Time Return 978.43 |
1 | Acquisition by Isaac Zacharias of 9395 shares of Shockwave Medical subject to Rule 16b-3 | 02/02/2024 |
2 | Disposition of 1987 shares by Godshall Douglas Evan of Shockwave Medical at 231.74 subject to Rule 16b-3 | 03/28/2024 |
3 | Shockwave Medical stock target raised by Piper Sandler on FDA nod | 04/02/2024 |
4 | Johnson Johnson to Acquire Shockwave Medical | 04/05/2024 |
5 | Shockwave Medical Stock Rises After Johnson Johnson Buyout | 04/08/2024 |
6 | Shockwave Medical has positive Reducer data | 04/09/2024 |
7 | Does Johnson Johnsons Latest Acquisition Make It a No-Brainer Buy | 04/10/2024 |
8 | 5 Things To Know In Investing This Week - The Shockwave Takeover Issue | 04/11/2024 |
9 | Whats in Store for Thermo Fisher in Q1 Earnings | 04/15/2024 |
10 | Johnson Johnson Q1 Earnings Slight Gains Amid Adjusted Forecasts | 04/16/2024 |
11 | Want to Double Your Tax Refund in 2024 7 Stocks to Buy Now. | 04/18/2024 |
12 | Disposition of 4000 shares by Isaac Zacharias of Shockwave Medical at 260.36 subject to Rule 16b-3 | 04/22/2024 |
Begin Period Cash Flow | 156.6 M |
Shockwave |
Shockwave Medical Relative Risk vs. Return Landscape
If you would invest 22,450 in Shockwave Medical on January 24, 2024 and sell it today you would earn a total of 10,404 from holding Shockwave Medical or generate 46.34% return on investment over 90 days. Shockwave Medical is currently generating 0.6318% in daily expected returns and assumes 2.3267% risk (volatility on return distribution) over the 90 days horizon. In different words, 20% of stocks are less volatile than Shockwave, and 88% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Shockwave Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Shockwave Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Shockwave Medical, and traders can use it to determine the average amount a Shockwave Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2715
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | SWAV | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.33 actual daily | 20 80% of assets are more volatile |
Expected Return
0.63 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
0.27 actual daily | 21 79% of assets perform better |
Based on monthly moving average Shockwave Medical is performing at about 21% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Shockwave Medical by adding it to a well-diversified portfolio.
Shockwave Medical Fundamentals Growth
Shockwave Stock prices reflect investors' perceptions of the future prospects and financial health of Shockwave Medical, and Shockwave Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Shockwave Stock performance.
Return On Equity | 0.25 | ||||
Return On Asset | 0.0938 | ||||
Profit Margin | 0.20 % | ||||
Operating Margin | 0.22 % | ||||
Current Valuation | 12.07 B | ||||
Shares Outstanding | 37.51 M | ||||
Price To Earning | 178.55 X | ||||
Price To Book | 18.38 X | ||||
Price To Sales | 16.83 X | ||||
Revenue | 730.23 M | ||||
Gross Profit | 424.74 M | ||||
EBITDA | 176.35 M | ||||
Net Income | 147.28 M | ||||
Cash And Equivalents | 224.91 M | ||||
Cash Per Share | 6.26 X | ||||
Total Debt | 770.61 M | ||||
Debt To Equity | 0.15 % | ||||
Current Ratio | 5.32 X | ||||
Book Value Per Share | 18.08 X | ||||
Cash Flow From Operations | 196.05 M | ||||
Earnings Per Share | 3.84 X | ||||
Market Capitalization | 12.33 B | ||||
Total Asset | 1.57 B | ||||
Retained Earnings | 110.47 M | ||||
Working Capital | 1.12 B | ||||
About Shockwave Medical Performance
To evaluate Shockwave Medical Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Shockwave Medical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Shockwave Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Shockwave Medical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Shockwave's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 411.68 | 293.84 | |
Return On Tangible Assets | 0.10 | 0.11 | |
Return On Capital Employed | 0.11 | 0.12 | |
Return On Assets | 0.09 | 0.1 | |
Return On Equity | 0.22 | 0.23 |
Things to note about Shockwave Medical performance evaluation
Checking the ongoing alerts about Shockwave Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Shockwave Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Over 95.0% of the company shares are owned by institutional investors | |
Latest headline from benzinga.com: Disposition of 4000 shares by Isaac Zacharias of Shockwave Medical at 260.36 subject to Rule 16b-3 |
- Analyzing Shockwave Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Shockwave Medical's stock is overvalued or undervalued compared to its peers.
- Examining Shockwave Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Shockwave Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Shockwave Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Shockwave Medical's stock. These opinions can provide insight into Shockwave Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shockwave Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Shockwave Stock please use our How to Invest in Shockwave Medical guide.Note that the Shockwave Medical information on this page should be used as a complementary analysis to other Shockwave Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Shockwave Stock analysis
When running Shockwave Medical's price analysis, check to measure Shockwave Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shockwave Medical is operating at the current time. Most of Shockwave Medical's value examination focuses on studying past and present price action to predict the probability of Shockwave Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shockwave Medical's price. Additionally, you may evaluate how the addition of Shockwave Medical to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Shockwave Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shockwave Medical. If investors know Shockwave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shockwave Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.69) | Earnings Share 3.84 | Revenue Per Share 19.894 | Quarterly Revenue Growth 0.409 | Return On Assets 0.0938 |
The market value of Shockwave Medical is measured differently than its book value, which is the value of Shockwave that is recorded on the company's balance sheet. Investors also form their own opinion of Shockwave Medical's value that differs from its market value or its book value, called intrinsic value, which is Shockwave Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shockwave Medical's market value can be influenced by many factors that don't directly affect Shockwave Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shockwave Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Shockwave Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shockwave Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.